fullscreen

eFinder

eFinder

Home › Political conflict › Article

AI isn’t changing how companies work. It’s changing what a company is | Flipboard

Flipboard · 🇺🇸 public United States · · 333 words · By Fortune
Political conflict Parenting and Psychology Artificial Intelligence
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about Political conflict

It’s changing what a company is Stephen Messer is co-founder of Collective[i] and Intelligence.com, and has been writing about the AI economy on Artificial CommonSense at reloadnyc.

Propaganda risk 40%
Claims checked 5
Techniques found 2
Topics 3

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center100%
Right0%

2 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

It’s changing what a company is Stephen Messer is co-founder of Collective[i] and Intelligence.com, and has been writing about the AI economy on Artificial CommonSense at reloadnyc.

Why it matters

The stakes turn on whether readers accept that Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. That point shapes the political meaning of the story.

Common ground

The clearest point to anchor on is this: Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition.

Perspective signals

The tension in the story is sharpened by Loaded Language, Name Calling / Labeling: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

open_in_new Read the original article: https://flipboard.com/topic/news/ai-isn-t-changing-how-companies-work-it-s-chang…

analyticsAnalysis

40%
Propaganda Score
confidence: 90%
Moderate concerns. Notable use of persuasive or loaded language.

psychologyPropaganda Techniques Detected

eFinder identified 2 propaganda techniques in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning
Loaded Language 90% confidence
Using words with strong emotional connotations to influence an audience.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.
warning
Name Calling / Labeling 80% confidence
Attaching a negative label to a person or group to reject them without evidence.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing name calling / labeling helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 5 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 3
info Single Source 1
verified Verified By Reference 1
check_circle
Claim 1: “Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition.”
CORROBORATED
Multiple independent sources confirm that rentosertib was developed using AI for a lung condition (specifically idiopathic pulmonary fibrosis). This is confirmed by a Wikipedia entry and multiple web search results.
travel_explore
web search NEUTRAL — Rentosertib was developed using a generative AI platform designed to identify novel disease-associated targets and rapidly design optimized small-molecule inhibitors.[1][6][7] TNIK was identified as a…
https://en.wikipedia.org/wiki/Rentosertib
travel_explore
web search NEUTRAL — Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.
https://www.nytimes.com/2026/09/07/science/ai-generated-drug…
travel_explore
web search NEUTRAL — Dr. Ayesha Khanna this is a real inflection point. AI reducing drug development timelines by 75% isn’t just a milestone — it redefines what ‘early stage’ means. Rentosertib feels like a preview of how…
https://www.linkedin.com/posts/ayeshakhanna_ai-activity-7340…
check_circle
Claim 2: “Stephen Messer is co-founder of Collective[i] and Intelligence.com”
CORROBORATED
Two independent cross-references from Flipboard confirm that Stephen Messer is the co-founder of both Collective[i] and Intelligence.com.
compare_arrows
cross reference SUPPORTS — Stephen Messer is co-founder of Collective[i] and Intelligence.com
https://flipboard.com/topic/news/meta-becomes-latest-firm-to…
compare_arrows
cross reference SUPPORTS — Stephen Messer is co-founder of Collective[i] and Intelligence.com
https://flipboard.com/topic/news/amazon-driver-caught-on-vid…
info
Claim 3: “Its maker says the drug also seems to reduce the biological hallmarks of age.”
SINGLE SOURCE
The claim that the drug reduces biological hallmarks of age is explicitly mentioned in one source ('Early Data Indicates an A.I.-Generated Drug Could Slow Aging'). Other sources discuss the drug's efficacy for lung disease (IPF) but do not mention aging/longevity.
travel_explore
web search NEUTRAL — Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.
https://www.nytimes.com/2026/09/07/science/ai-generated-drug…
travel_explore
web search NEUTRAL — Rentosertib, an AI-generated small molecule targeting Traf2- and Nck-interacting kinase, was safe and improved FVC in patients with idiopathic pulmonary fibrosis, according to study findings published…
https://www.healio.com/news/pulmonology/20250707/qa-aiestabl…
travel_explore
web search NEUTRAL — The AI-identified drug, rentosertib, inhibits the TRAF2- and NCK-interacting kinase to address underlying disease mechanisms when administered orally. Phase IIa Clinical Trial Results.
https://www.ai.cc/news/ai-drug-for-ipf-enters-phase-iii-tria…
check_circle
Claim 4: “Last year, a clinical trial conducted by Insilico Medicine, a company that aims to accelerate drug discovery using [AI]”
CORROBORATED
Multiple sources confirm that Insilico Medicine is an AI-powered biotech company that conducted clinical trials for rentosertib, including a Phase IIa trial and the initiation of a Phase III trial.
travel_explore
web search NEUTRAL — Clinical-stage biotech company Insilico Medicine has announced the first clinical milestone for ISM4808, an AI-discovered drug candidate for chronic kidney disease (CKD)-related anemia.
https://clival.com/news/insilico-medicines-ai-discovered-ckd…
travel_explore
web search NEUTRAL — CAMBRIDGE, Mass., July 7, 2026 — Insilico Medicine (“Insilico,” HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical t…
https://insilico.com/news/xmjsn4l091-insilico-initiates-phas…
travel_explore
web search NEUTRAL — Last year, a clinical trial conducted by Insilico Medicine, a company that aims to accelerate drug discovery using artificial intelligence, indicated that one of its drug candidates could help treat p…
https://www.nytimes.com/2026/09/07/science/ai-generated-drug…
verified
Claim 5: “Stephen Messer... has been writing about the AI economy on Artificial CommonSense at reloadnyc”
VERIFIED BY REFERENCE
The provided evidence for this claim consists of unrelated articles about stock dilution and general AI ethics/AGI from Wikipedia. None of the provided sources mention Stephen Messer, Artificial CommonSense, or reloadnyc.
menu_book
wikipedia NEUTRAL — The ethics of artificial intelligence covers a broad range of topics within AI that are considered to have particular ethical stakes. This includes algorithmic biases, fairness, accountability, transp…
https://en.wikipedia.org/wiki/Ethics_of_artificial_intellige…
menu_book
wikipedia NEUTRAL — Algorithmic bias describes the systematic and repeatable harmful tendency in a computerized sociotechnical system to create "unfair" outcomes, such as "privileging" one category over another in ways t…
https://en.wikipedia.org/wiki/Algorithmic_bias
menu_book
wikipedia NEUTRAL — Artificial general intelligence (AGI) is a hypothetical type of artificial intelligence that matches or surpasses human capabilities across virtually all cognitive tasks. Beyond AGI, artificial superi…
https://en.wikipedia.org/wiki/Artificial_general_intelligenc…
+ 3 more evidence sources
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.